The text discusses various studies and trials related to the treatment of non-metastatic colon cancer, including the use of fluorouracil/folinic acid, encorafenib, binimetinib, cetuximab, aspirin, oxaliplatin, and capecitabine. The importance of analyzing a higher number of lymph nodes for colon cancer survival is also highlighted.